News
The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...
The US Food and Drug Administration (FDA) has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 ...
The Lumipulse Alzheimer's blood test is the first of a new generation of tests that may replace brain scans and spinal taps to detect the disease.
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
The U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer's disease. The Lumipulse ...
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...
The FDA has approved the Lumipulse Plasma Ratio test, a groundbreaking blood test for early dementia detection. This less ...
The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...
The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...
U.S. regulators have approved the first blood test to help diagnose Alzheimer’s disease, potentially making it easier to find ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results